Inflazome UK Ltd.
🇬🇧United Kingdom
PK Study in Patients With Parkinson's Disease With IZD174
- First Posted Date
- 2020-04-08
- Last Posted Date
- 2020-12-04
- Lead Sponsor
- Inflazome UK Ltd
- Registration Number
- NCT04338997
Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334
Phase 1
Completed
- Conditions
- Healthy VolunteersCryopyrin Associated Periodic Syndrome
- Interventions
- Drug: Placebos
- First Posted Date
- 2019-09-11
- Last Posted Date
- 2020-03-02
- Lead Sponsor
- Inflazome UK Ltd
- Target Recruit Count
- 64
- Registration Number
- NCT04086602
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With Inzomelid
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2020-03-27
- Lead Sponsor
- Inflazome UK Ltd
- Target Recruit Count
- 80
- Registration Number
- NCT04015076
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Queensland, Australia
© Copyright 2025. All Rights Reserved by MedPath